SCOPE 2026
- Start Date:
02 Feb 2026
- End Date:
05 Feb 2026
- Location:
Orlando, FL
- Region:
North America
- Booth #:
1101
Driving global clinical trial momentum
Visit us at SCOPE, booth #1101
Meet our experts and discover how we can support your clinical trial needs from pre-clinical through commercialization. Here’s what’s in store at SCOPE:
Exciting highlights
Wednesday, Feb 4th at 11:15am
AI-driven case intake benefits and key implementation considerations
Speaker: Neil Walker, Optimization Director
Pharmacovigilance (PV) case intake is critical in adverse event (AE) reporting, ensuring compliance with global regulatory requirements and maintaining patient safety. However, for many years, the increasing complexity and volume of individual case safety reports (ICSRs) have presented challenges for organizations using manual workflows.
Read more about this talk
Traditional case intake methods, which include receiving, transcribing and validating reports, were becoming increasingly unsustainable as regulatory expectations evolved and the volume of cases increased. Despite the optimism shown by some technology vendors that the use of artificial intelligence (AI), there was scant evidence of significant deployment of AI in real functioning pharmacovigilance systems over the years. Barriers to adaptation were attributed to significant costs of the system configuration and datasets needs for both implementation and ongoing maintenance.
In this presentation, PPD™ Functional Service Partnership (FSP) Pharmacovigilance solutions experts:
- Discuss barriers to adoption of earlier systems and two key factors which have significantly reduced these barriers over the past four years.
- Re-examine the benefits of AI-assisted case intake and processing.
Tuesday, Feb 3rd at 12:45pm
Agentic AI and the Future of Clinical Trial Design and Execution
Speaker: Krishna Cheriath, Vice President, Digital and AI
We are entering the era of agentic AI—systems capable not just of analysis, but autonomous reasoning and adaptive decision-making. This session examines how agentic AI can reshape trial design, site selection, patient recruitment, and monitoring. It explores real-world pilots and governance frameworks that ensure safety, transparency, and human oversight, while unlocking efficiency and innovation.
Wednesday, Feb 4th at 12:30pm
Designing Patient-First Digital Strategies to Accelerate Clinical Trials
Speaker: Jenna McDonnell, Executive Director, Patient First Digital Solutions
Discover how patient-first digital strategies are reshaping clinical trial recruitment and retention. This session explores how AI-driven social listening and patient population science insights help identify and engage the most demographically and epidemiologically appropriate patients—faster and more effectively. Learn how precision pre-screeners, SMART screening and digital approaches reduce burden enhancing broader trial accessibility, improve retention, and enhance scientific validity and data quality, ultimately delivering more inclusive, efficient, and higher-quality clinical trials.
Meet our experts and explore solutions to streamline and accelerate your trial
AI-powered platform for seamless E2E data curation and real-time decision making.
Proven to provide up to 50% faster study build, 30% faster startup, 40% faster query resolution, 50% faster database lock, and 50% faster CSR results.
Innovative CDMO and CRO solutions to fast-track your drug development journey through a single partner.
30+ years of experience in 160+ countries, providing top-tier staff and tailored expertise.
Filling small gaps or supporting large-scale programs, our FSP solutions ensure you meet timelines.
Transform patient experience with digitally-enabled solutions for recruitment, engagement, and data collection.
A customized suite of evidence-based solutions to demonstrate real world effectiveness, safety, and value throughout the product life cycle.